Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183456 · ClinicalTrials.gov registry record · Phase 2
A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs
A Phase 2 study of HIV Infections and Sexually Transmitted Diseases, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 746
- Enrollment target
- 1
- Study location
NCT00183456: Completed Phase 2 study of HIV Infections and Sexually Transmitted Diseases, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT00183456 is a Phase 2 study of HIV Infections and Sexually Transmitted Diseases that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 746 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00183456, a Phase 2 study of HIV Infections and Sexually Transmitted Diseases, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 746 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the effectiveness of a peer outreach intervention in preventing HIV infection in adults at high risk for contracting HIV and other sexually transmitted diseases (STDs).
Primary Outcome
Number of participants that had 2 or more sex partners in the past 90 days.
Conditions Studied
Interventions
- BEHAVIORAL Peer-oriented intervention
- BEHAVIORAL Group cognitive behavioral therapy (CBT)
Study Locations (1)
Maryland
- The Lighthouse - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 746 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
What the finished NCT00183456 record still lists
NCT00183456 is an interventional study that assigns participants to a tested intervention. The registered 746 participants enrollment target is mid-sized for trials with a published cap, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (68% higher).
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Peer-oriented intervention is the first listed.
NCT00183456 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00183456 about?
NCT00183456 is a clinical study titled "A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs". This study will determine the effectiveness of a peer outreach intervention in preventing HIV infection in adults at high risk for contracting HIV and other sexually transmitted diseases (STDs).
What is the current status of trial NCT00183456?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 746 participants. The study started on 2005-09. Estimated completion is 2009-12.
What conditions does trial NCT00183456 study?
This clinical trial studies the following conditions: HIV Infections, Sexually Transmitted Diseases.
What interventions are being tested in trial NCT00183456?
The interventions under investigation include: Peer-oriented intervention (BEHAVIORAL), Group cognitive behavioral therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00183456?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00183456 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00183456's enrollment target sits among peer trials
746 43rd of 542 higher than 500 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
RECRUITING · Phase 2
-
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RECRUITING · Phase 2
-
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
RECRUITING · Phase 2
-
Imaging Immune Activation in HIV by PET-MR
RECRUITING · Phase 2
-
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05619185 · 744 participants · NA
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
- NCT06417814 · 744 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT07046351 · 744 participants · NA
weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents
- NCT07199569 · 744 participants · Phase 2
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia